Tim Watkins, the CMO & Head of Development of $CTNM, sold 3,611 shares of the company on 12-29-2025 for an estimated $43,558. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $CTNM stock.
$CTNM Insider Trading Activity
$CTNM insiders have traded $CTNM stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTNM stock by insiders over the last 6 months:
- DANIEL S. LORRAIN (Chief Scientific Officer) sold 4,170 shares for an estimated $51,009
- TIM WATKINS (CMO & Head of Development) sold 3,611 shares for an estimated $43,558
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CTNM Hedge Fund Activity
We have seen 32 institutional investors add shares of $CTNM stock to their portfolio, and 41 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. added 2,122,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $24,933,500
- BALYASNY ASSET MANAGEMENT L.P. added 951,320 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,178,010
- MILLENNIUM MANAGEMENT LLC added 513,644 shares (+388.0%) to their portfolio in Q3 2025, for an estimated $6,035,317
- SATURN V CAPITAL MANAGEMENT LP removed 319,348 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,752,339
- ALTIUM CAPITAL MANAGEMENT LLC removed 303,857 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,570,319
- BAKER BROS. ADVISORS LP removed 234,830 shares (-75.1%) from their portfolio in Q3 2025, for an estimated $2,759,252
- VANGUARD GROUP INC added 220,231 shares (+29.6%) to their portfolio in Q3 2025, for an estimated $2,587,714
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CTNM Analyst Ratings
Wall Street analysts have issued reports on $CTNM in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 11/24/2025
- RBC Capital issued a "Outperform" rating on 11/21/2025
- Leerink Partners issued a "Outperform" rating on 09/25/2025
To track analyst ratings and price targets for $CTNM, check out Quiver Quantitative's $CTNM forecast page.
$CTNM Price Targets
Multiple analysts have issued price targets for $CTNM recently. We have seen 4 analysts offer price targets for $CTNM in the last 6 months, with a median target of $20.5.
Here are some recent targets:
- Joel Beatty from Baird set a target price of $14.0 on 11/24/2025
- Brian Abrahams from RBC Capital set a target price of $22.0 on 11/21/2025
- Faisal Khurshid from Leerink Partners set a target price of $20.0 on 09/25/2025
- Jeffrey Hung from Morgan Stanley set a target price of $21.0 on 08/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
